Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01
Published March 21, 2018 · Recall initiated: February 7, 2018
Summary
FDA records drug Class I recall D-0597-2018, published March 21, 2018 and initiated February 7, 2018. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 29, 680 vials; Lot: Lot 71330DD EXP. 11/1/2018. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
What to do
Voluntary: Firm initiated · Letter
Get an email if HYDROMORPHONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot 71330DD EXP. 11/1/2018.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPsoriasin Daytime Relief Cream with Vitamin D & Oatmeal, (Coal Tar 1.25%), packagedin 57 g plastic tubes,March 21, 2018
- FDAClocortolone Pivalate Cream, 0.1%, 90-gram tube, Rx only, Distributed by: Dr. Reddy's Laboratories, Inc.March 21, 2018
- FDAHYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only,September 27, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: TevaAugust 16, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100August 16, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per cartonAugust 16, 2017
Questions about this recall
Was Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. Hospira, Inc., Lake forest, IL 60045 USA. NDC: 0409-2634-01 recalled?
Yes. FDA published recall D-0597-2018 on March 21, 2018. Reported hazard: Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROMORPHONE HYDROCHLORIDE.